Proanthocyanidin ameliorates BCCAO-induced neuroinflammation in cerebral ischemia–reperfusion injury (CIRI) in rats by targeting NF-κB/NLRP3 inflammasome pathway
Naunyn-Schmiedeberg's Archives of Pharmacology · 06.11.2026
DOI: 10.1007/s00210-026-06012-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 06.11.2026. Verfasst von Pradeep Kant Pachauri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
- Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India. sivaprasad.panda@gla.ac.in.
Zitieren
APA
Pachauri, P. K., & Panda, S. P. (2026). Proanthocyanidin ameliorates BCCAO-induced neuroinflammation in cerebral ischemia–reperfusion injury (CIRI) in rats by targeting NF-κB/NLRP3 inflammasome pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06012-2
Vancouver
Pachauri PK, Panda SP. Proanthocyanidin ameliorates BCCAO-induced neuroinflammation in cerebral ischemia–reperfusion injury (CIRI) in rats by targeting NF-κB/NLRP3 inflammasome pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06012-2
BibTeX
@article{Pachauri2026,
author = {Pachauri, Pradeep Kant and Panda, Siva Prasad},
title = {Proanthocyanidin ameliorates BCCAO-induced neuroinflammation in cerebral ischemia–reperfusion injury (CIRI) in rats by targeting NF-κB/NLRP3 inflammasome pathway},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-06012-2}
}
EUVIMED